Actavis Ducks Endo's Opana False Ad Suit In NJ
A New Jersey federal judge on Tuesday nixed a false advertising and consumer fraud suit brought by Endo Pharmaceuticals Inc. against Actavis Inc. over generic versions of its Opana ER painkiller,...To view the full article, register now.
Already a subscriber? Click here to view full article